Lisinopril vs Tofacitinib
Lisinopril vs Tofacitinib: Overview
This comparison examines the pharmacological differences between Lisinopril and Tofacitinib.
Mechanism of Action
Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.
Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.
Pharmacokinetics
Half-life: Lisinopril β 12 hours; Tofacitinib β 3.2 hours.
Chemical Properties
Molecular Formula: Lisinopril β C21H31N3O5; Tofacitinib β C16H20N6O.
Molecular Weight: Lisinopril β 405.4900 g/mol; Tofacitinib β 312.3700 g/mol.
Type: Lisinopril β Small molecule; Tofacitinib β Small molecule.